According to a recent LinkedIn post from Pulnovo Medical, the company has hired Mathias Bouzereau as Senior Business Development Director, International. The post highlights his more than 25 years of global MedTech experience, including senior commercial and strategic roles at Medtronic and Occlutech.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The post suggests that Bouzereau has a track record in driving international expansion, portfolio growth, and double‑digit revenue performance across global markets. His background, including an MBA from IMD Business School and training in France and the U.K., is presented as reinforcing Pulnovo Medical’s efforts to build its international presence.
For investors, the appointment may indicate a strategic emphasis on scaling Pulnovo’s pulmonary hypertension and heart failure portfolio beyond its existing markets. If his experience in strategic partnerships and market expansion translates into successful execution, it could support revenue growth and strengthen the company’s competitive position in the global MedTech space.
The focus on international business development also suggests that Pulnovo may prioritize new market entries or deeper penetration in current geographies. Over time, this type of leadership hire can be a precursor to broader commercial initiatives, including distribution alliances, licensing deals, or regional expansions that may influence the company’s long‑term growth trajectory.

